Selenide-Driven Reactive Oxygen Species Activation and Fe(II) Regeneration for Enhanced Nanocatalytic Antibacterial Therapeutics.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40344503.
- Also identified by DOI 10.1002/adhm.202501021.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Fenton-based nanocatalytic therapy has attracted widespread attention for its high efficiency and safety. Nevertheless, Fe<sup>2+</sup> regeneration, as the rate-limiting step of Fenton reaction, hinders the ROS-induced oxidative killing. Herein, a Fe<sup>2+</sup> auto-regeneration strategy is exemplified by 2D FeSe<sub>2</sub> nanosheets to break the rate limitation of Fenton reaction and subsequently enhances the antibacterial oxidative damage via dual ROS generation pathways. To be specific, the Se species accelerate the Fe<sup>3+</sup> reduction to maintain high ·OH productivity of Fe<sup>2+</sup>-mediated Fenton reaction, which is accompanied by the production of H<sub>2</sub>Se in the presence of H<sup>+</sup>. The H<sub>2</sub>Se further converts O<sub>2</sub> into O<sub>2</sub> <sup>·-</sup> and synergistically breaks the oxidative threshold of bacteria, leading to irreversible bacterial death with glutathione depletion, lipid peroxidation, and membrane destruction. In summary, the FeSe<sub>2</sub>-mediated Fe<sup>2+</sup> auto-regeneration and ROS self-production pathways largely elevate its oxidative killing capability, providing a potential ROS enhancement strategy for broad-spectrum nonantibiotic bacterial disinfection.
Medical subject headings
- Reactive Oxygen Species
- Anti-Bacterial Agents
- Iron